Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.585 AUD | +0.86% | -2.50% | +9.35% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 01/12/01 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Thomas Jarrett
COO | Chief Operating Officer | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/01 |
Justin Ward
BRD | Director/Board Member | - | 01/16/01 |
Director/Board Member | - | 29/17/29 | |
Daniel Astudillo
SAM | Sales & Marketing | - | 01/18/01 |
Maggie Niewidok
SEC | Corporate Secretary | - | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
CHM | Chairman | 70 | 24/18/24 |
Alan Dunton
BRD | Director/Board Member | 70 | 14/20/14 |
Director/Board Member | - | 29/17/29 | |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/01 |
James Graham
CEO | Chief Executive Officer | - | 01/12/01 |
Justin Ward
BRD | Director/Board Member | - | 01/16/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 203,701,863 | 125,491,504 ( 61.61 %) | 0 | 61.61 % |
Company contact information
Recce Pharmaceuticals Ltd.
Salesforce Tower 180 George Street
2000, Sydney
+61 2 9256 2505
http://www.recce.com.auSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.35% | 79.23M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- RCE Stock
- Company Recce Pharmaceuticals Ltd